Effects of calcitonin gene-related peptide on membrane currents in mammalian cardiac myocytes
β Scribed by Toshiaki Nakajima; Reiko Takikawa; Tsuneaki Sugimoto; Yoshihisa Kurachi
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 687 KB
- Volume
- 419
- Category
- Article
- ISSN
- 0031-6768
No coin nor oath required. For personal study only.
β¦ Synopsis
We examined the effects of calcitonin gene-related peptide (CGRP) on the membrane currents of single atrial and ventricular cells of guinea pig heart. The tightseal whole-cell voltage-clamp technique was used. In atrial cells, like isoproterenol, CGRP increased the L-type Ca channel current (ICa.L) in a concentration-dependent manner. Human CGRP-(8-37), a putative CGRP receptor antagonist, completely abolished the CGRP-induced increase of ICa.L. Although the effects of CRGP were similar to those of isoproterenol, propranolol, a fl-adrenergic receptor antagonist, did not affect the CGRP-induced increase of ICa.L. After ICa.L had been maximally activated by isoproterenol (2 gM) or intracellular cyclic adenosine 5'-monophosphate (100 gM), CGRP failed to increase Ica.L. Acetylcholine antagonized the effects of CGRP on Ica.L. Unlike the effects on atrial cells, CGRP had no significant effects on the membrane currents of ventricular myocytes. Thes results indicate that CGRP increases Ica.L via adenylate cyclase activation by binding to specific membrane receptors in cardiac atrial myocytes. Furthermore, CGRP receptors are expressed in atrial cells but probably not in ventricular cells.
π SIMILAR VOLUMES
The effects of lithium on brain regional concentrations of substance P (SP)-, neurokinin A (NKA)-, calcitonin gene-related peptide (CGRP)-and neuropeptide Y (NPY)-like immunoreactivities (-LI) were studied in rat. In the pilot study, rats were divided into three groups that were administered vehicle
The haemodynamic responses to microinjections of rat or human calcitonin gene-related peptide (CGRP) into the nucleus tractus solitarius (NTS) of rats were studied. 40 fmol rCGRP did not significantly modify cardiovascular parameters, but 0.2 pmol decreased blood pressure and heart rate (HR), wherea